selected publications
- MRE11 mobilizes CGAS and drives ZBP1-dependent necroptosis. Cell research. 2024 Academic Article GET IT
- Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-XL in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients. Molecular oncology. 2023 Academic Article GET IT
-
Silver-Based Terpyridine Complexes as Antitumor Agents.
Chemistry (Weinheim an der Bergstrasse, Germany).
2023
Academic Article
GET IT
Times cited: 1 -
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis.
Oncoimmunology.
2022
Academic Article
GET IT
Times cited: 2 -
Toll-like receptors: New targets for multiple myeloma treatment?.
Biochemical pharmacology.
2022
Review
GET IT
Times cited: 5